Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIP.L Regulatory News (CIP)

  • There is currently no data for CIP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Payment of Additional Director Fees

25 Apr 2022 08:45

RNS Number : 1826J
CIP Merchant Capital Ltd
25 April 2022
 

 

25 April 2022

 

CIP MERCHANT CAPITAL LIMITED

("CIP" or the "Company")

 

Payment of Additional Director Fees

 

The Board of CIP announces that it has agreed to make a one-off additional payment of, in aggregate, £57,500, to the Company's directors in connection with the additional work undertaken by the Board, beyond the scope of their existing contractual arrangements with the Company, in relation to addressing Corporation Financière Européenne S.A.'s ("CFE") protracted stake building, announcement of a possible offer for CIP, and subsequent hostile offer for CIP, over the past 18 months (the "Additional Director Fees").

 

The Additional Director Fees are to be paid as follows:

 

Director

Additional Director Fees

Adrian Collins

£17,500

John Falla

£15,000

Robert King

£12,500

Piero Sansalone

£12,500

 

 

Related Party Transaction

 

The payment of the Additional Director Fees is deemed to be a related party transaction under the AIM Rules. Due to the participation of all of the Company's directors, there is no director independent of the Additional Director Fees arrangement to provide the necessary AIM Rule 13 related party transaction opinion.

 

Accordingly, Strand Hanson Limited, the Company's Nominated Adviser, is satisfied that the Additional Director Fees are fair and reasonable, insofar as the Shareholders are concerned.

 

 

Enquiries:

 

CIP Merchant Capital Limited

Wikus van Schalkwyk

 

+44 1481 749363

Strand Hanson Limited (Financial & Nominated Adviser and Broker)

Stuart Faulkner / Matthew Chandler / James Bellman / Rob Patrick

+44 20 7409 3494

 

 

The information contained in this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 (which applies in the United Kingdom by operation of the European Union (Withdrawal) Act 2018 (as amended)). The person responsible for arranging release of this announcement on behalf of CIP is Adrian Collins.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDELBLLZLXBBV
Date   Source Headline
11th Feb 20207:00 amRNSNet Asset Value(s)
4th Feb 20207:00 amRNSNet Asset Value(s)
28th Jan 20207:00 amRNSNet Asset Value(s)
21st Jan 20207:00 amRNSNet Asset Value(s)
14th Jan 20207:00 amRNSNet Asset Value(s)
10th Jan 20205:38 pmRNSHolding(s) in Company
10th Jan 20203:18 pmRNSInvestment in Circassia Pharmaceuticals plc
7th Jan 20207:00 amRNSNet Asset Value(s)
31st Dec 20197:00 amRNSNet Asset Value(s)
24th Dec 20197:00 amRNSNet Asset Value(s)
17th Dec 20197:00 amRNSNet Asset Value(s)
10th Dec 20197:00 amRNSNet Asset Value(s)
3rd Dec 20197:00 amRNSNet Asset Value(s)
26th Nov 20197:00 amRNSNet Asset Value(s)
21st Nov 20193:35 pmRNSHolding(s) in Company
21st Nov 20192:50 pmRNSFurther Investment in Brave Bison Group plc
19th Nov 20197:00 amRNSNet Asset Value(s)
12th Nov 20197:00 amRNSNet Asset Value(s)
5th Nov 20197:00 amRNSNet Asset Value(s)
31st Oct 20191:53 pmRNSNotification of Major Shareholder
29th Oct 20197:00 amRNSNet Asset Value(s)
28th Oct 20199:14 amRNSDirectors' Dealing
22nd Oct 20197:00 amRNSNet Asset Value(s)
21st Oct 20199:50 amRNSDirectors' Dealing
18th Oct 201912:26 pmRNSHolding(s) in Company
15th Oct 20197:00 amRNSNet Asset Value(s)
10th Oct 20193:43 pmRNSHolding(s) in Company
8th Oct 20197:00 amRNSNet Asset Value(s)
4th Oct 20197:00 amRNSDirectors' Dealing
1st Oct 20197:00 amRNSNet Asset Value(s)
24th Sep 20197:00 amRNSNet Asset Value(s)
17th Sep 20197:00 amRNSNet Asset Value(s)
13th Sep 20194:09 pmRNSForm 8.3 - Proactis Holdings PLC - Update
13th Sep 20193:38 pmRNSHolding(s) in Company
13th Sep 20193:19 pmRNSForm 8.3 - Proactis Holdings PLC
10th Sep 20195:16 pmRNSInterim Result for the Period Ended 30 June 2019
10th Sep 20197:00 amRNSNet Asset Value(s)
3rd Sep 20197:00 amRNSNet Asset Value(s)
28th Aug 20197:00 amRNSNet Asset Value(s)
20th Aug 20197:00 amRNSNet Asset Value(s)
13th Aug 20197:00 amRNSNet Asset Value(s)
6th Aug 201910:46 amRNSHolding(s) in Company
6th Aug 201910:45 amRNSFurther Investment in Brave Bison Group plc
6th Aug 20197:00 amRNSNet Asset Value(s)
30th Jul 20194:18 pmRNSDirector Dealing
30th Jul 20197:01 amRNSForm 8.3 - Proactis Holdings PLC
30th Jul 20197:00 amRNSNet Asset Value(s)
23rd Jul 20197:00 amRNSNet Asset Value(s)
18th Jul 20194:19 pmRNSSixth Investment - Brave Bison Group plc
16th Jul 20197:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.